Omada Health

OMDA | NASDAQ

Price Alert Chart Builder DCF Calculator

$20.30

-$0.13 (-0.64%)

Sep 21, 2026, 2:02 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.64%

(1D)

Rating

Updated: Aug 11, 2026

59.8

Fundamentals Strong

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.21B

1D Range

20.12 20.66

52W Range

10.28 26.92

Valuation (TTM)

PE 324.29

PB 4.81

EV/EBITDA 84.47

Valuation (NTM)

Forward PE 46.58

Forward PEG 8.40

Price Target $25.88

Cash Flow

FCF Yield 0.5%

SBC Adj. FCF Yield -1.2%

SBC Impact -335.1%

Margins

Gross Margin 68.2%

Operating Margin -0.1%

FCF Margin 2.1%

Growth (CAGR)

Revenue 3Y | 5Y 42.9% | N/A

Dil EPS 3Y | 5Y 65.1% | N/A

FCF 3Y | 5Y 141.5% | N/A

Returns

ROA 1.3%

ROE 1.8%

ROIC -0.2%

Financial Health

Net Cash

$221.71M

Current Ratio 3.91

Interest Coverage -1.17

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, ...

Sector Healthcare

Industry Medical - Healthcare Information Services

Employees 946

IPO Date Jun 5, 2025

Website www.omadahealth.com

Fiscal Year January - December

Full Company Profile

Latest News

11 days ago · seekingalpha.com

Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript

11 days ago · globenewswire.com

Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day

SAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, will present its long-term financial targets at the company's inaugural Investor Day, being held today at the Four Seasons Hotel in New York, New York.

13 days ago · fool.com

Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares

Traded 31,457 shares with a transaction value of ~$735,150 based on a weighted average price of $23.37 per share. The activity involved shares equal to 2% of the total equity stake held before the filing, including direct transactions equal to 8% of the prior direct position.

1 month ago · seekingalpha.com

Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings

Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating. OMDA's product expansion, especially in diabetes and hypertension, is driving higher revenue per member and improving customer-lifetime-value through multi-program adoption. Channel partnerships with PBMs and health plans are lowering CAC, supporting scalable growth and better unit economics, while AI initiatives further enhance operational leverage.

1 month ago · zacks.com

Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

2 months ago · seekingalpha.com

Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

2 months ago · marketbeat.com

Omada Health Q2 Earnings Call Highlights

Omada Health NASDAQ: OMDA reported record second-quarter results for 2026, citing broad-based growth across its cardiometabolic programs, expanding channel partnerships and lower costs to serve members. The company also announced that President Wei-Li Shao will succeed Co-founder and Chief Executive Officer Sean Duffy as CEO on Jan. 1, 2027.

2 months ago · zacks.com

Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates

Omada Health, Inc. (OMDA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to a loss of $0.09 per share a year ago.

2 months ago · globenewswire.com

UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2026 results on Thursday, August 6, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at https://investors.omadahealth.com.